Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer

por VÄISÄNEN, MARJA-RIITTA, JUKKOLA-VUORINEN, ARJA, VUOPALA, KATRI S., SELANDER, KATRI S., VAARALA, MARKKU H.
Publicado 2013

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

por Ronkainen, Hanna, Hirvikoski, Pasi, Kauppila, Saila, Vuopala, Katri S, Paavonen, Timo K, Selander, Katri S, Vaarala, Markku H
Publicado 2011

Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma

por Ishikawa, Nobuhisa, Mazur, Witold, Toljamo, Tuula, Vuopala, Katri, Rönty, Mikko, Horimasu, Yasushi, Kohno, Nobuoki, Kinnula, Vuokko L
Publicado 2011

NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs

por Hämäläinen, Mari, Teppo, Hanna-Riikka, Skarp, Sini, Haapasaari, Kirsi-Maria, Porvari, Katja, Vuopala, Katri, Kietzmann, Thomas, Karihtala, Peeter
Publicado 2019

Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans

por Chandler, Madison R., Keene, Kimberly S., Tuomela, Johanna M., Forero-Torres, Andres, Desmond, Renee, Vuopala, Katri S., Harris, Kevin W., Merner, Nancy D., Selander, Katri S.
Publicado 2017